ArticleKidney research and clinical practice2017

Efficacy and safety of adding mizoribine to standard treatment in patients with immunoglobulin A nephropathy: A randomized controlled trial.

Keiji Hirai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.